1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Down Syndrome (DS): new trials by email Literature Review of Down Syndrome (DS) trials Research Report on Down Syndrome (DS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic Tool Epigallocatechin-3-gallate (EGCG) - Down Syndrome (DS) | Phase 2 | Completed | Parc de Salut Mar | 87 | 2012-02-01 | 2016-02-11 |
Alzheimer Disease (1) · Down Syndrome (1)
Abnormalities, Multiple (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Chromosome Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dementia (1) · Genetic Diseases, Inborn (1) · Intellectual Disability (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Neurologic Manifestations (1)
Spain (1)